BEAT ▲ +7.7% - HeartBeam, Inc. $BEAT HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP) 26-OCT-2026 08:32 AM ET